Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative. - Stokman G; van den Hoek AM; Denker Thorbekk D; Pieterman EJ; Skovgård Veidal S; Basta B; Iruarrizaga-Lejarreta M; van der Hoorn JW; Verschuren L; Berbée JFP; Rensen PCN; Skjaeret T; et al. (Liver international : official journal of the International Association for the Study of the Liver, 2020)